The Global Celiac Drugs Market size is projected to grow at a CAGR of 5.8% during the forecast period 2018-2028. The growth in this market can be attributed to the increasing prevalence of celiac disease, raising awareness about celiac disease, and technological advancements in the field of celiac drugs. In this report, we have segmented the global celiac drugs market on the basis of type, application, and region.
Celiac drugs are medications that are used to treat celiac disease. Celiac disease is a condition in which the body cannot tolerate gluten, a protein found in wheat, barley, and rye. When people with celiac disease eat foods that contain gluten, they may experience abdominal pain, diarrhea, bloating, and fatigue. Celiac disease is a condition that causes damage to the lining of the small intestine and prevents it from absorbing parts of food that are important for staying healthy. People who have celiac disease cannot tolerate a protein called gluten, which is found in wheat, rye, and barley. When people with celiac disease eat foods or use products that contain gluten, their immune system responds by damaging the small intestine.
On the basis of Type, the global celiac drugs market is segmented into first line of treatment and second line of treatment.
First line of treatment is the initial course of therapy that is recommended for a particular disease or condition. It is usually the most effective and least invasive form of treatment. First-line treatments are typically used before second-line treatments are considered. The first line of treatment for celiac disease is a gluten-free diet. This means avoiding all foods that contain wheat, rye, and barley. People with celiac disease must be careful to avoid even trace amounts of gluten in their diet. The gluten-free diet is the only currently available treatment for celiac disease. It is a lifelong diet that requires careful planning and labels reading to avoid hidden sources of gluten.
Second line of treatment is a type of celiac drug that is used when the first line of treatment fails. Second-line treatments are typically more aggressive and have more side effects than first-line treatments. Some common second-line treatments for celiac disease include immunosuppressants, anti-inflammatory drugs, and biological therapies. Second line of treatment for celiac disease is generally a gluten-free diet. This means eliminating all foods that contain gluten from the diet. This can be a challenge, as gluten is found in many common foods, such as bread, pasta, cereal, and baked goods.
On the basis of Application, the global celiac drugs market is segmented into men, women, and children.
On the basis of Region, the global celiac drugs market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The celiac drugs market in North America is expected to grow at a significant rate during the forecast period. This growth can be attributed to the rising prevalence of celiac disease and the availability of advanced treatments in this region. Moreover, increasing awareness about the disease and its treatment options is also fueling the market growth in North America. The European region is expected to be the second-largest market for celiac drugs due to the high prevalence of celiac disease in this region. The prevalence of the celiac disease is estimated to be about one in every 100 people in Europe. Moreover, the availability of new and innovative treatments and the increasing awareness about celiac disease are also expected to drive market growth in this region.
The Asia Pacific region is expected to be the fastest-growing market for celiac drugs due to the increasing prevalence of celiac disease in this region. The high growth of this region is attributed to the growing awareness about celiac disease and the rise in disposable incomes. China and India are expected to be the major contributors to the market growth in this region. The Middle East & Africa region is expected to witness moderate growth during the forecast period due to the low prevalence of celiac disease in this region. However, the availability of new and innovative treatments and the increasing awareness about celiac disease are expected to drive market growth in this region.
The global celiac drugs market is growing due to the increase in the number of people suffering from celiac disease. The number of people diagnosed with celiac disease has been increasing over the years, owing to the awareness about the condition and the availability of better diagnostic tools. This has resulted in an increased demand for celiac drugs globally. Moreover, the development of new and improved treatments for celiac disease is another factor that is expected to drive the growth of the global celiac drugs market during the forecast period.
Up Market Research published a new report titled “Celiac Drugs Market research report which is segmented by Types (First Line Of Treatment, Second Line Of Treatment), By Applications (Men, Women, Children), By Players/Companies ADMA Biologics, Amgen, Anthera Pharmaceuticals, Bayer, Biogen, BioLineRx, Biotest, Bristol-Myers Squibb, Celgene, Celimmune, F Hoffmann-La Roche, ImmunogenX, Immunomedics, ImmusanT, Innovate Biopharmaceuticals, Johnson & Johnson, Kedrion Biopharma, LFB Group, Merck, Novartis”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
|Report Attributes||Report Details|
|Report Title||Celiac Drugs Market Research Report|
|By Type||First Line Of Treatment, Second Line Of Treatment|
|By Application||Men, Women, Children|
|By Companies||ADMA Biologics, Amgen, Anthera Pharmaceuticals, Bayer, Biogen, BioLineRx, Biotest, Bristol-Myers Squibb, Celgene, Celimmune, F Hoffmann-La Roche, ImmunogenX, Immunomedics, ImmusanT, Innovate Biopharmaceuticals, Johnson & Johnson, Kedrion Biopharma, LFB Group, Merck, Novartis|
|Regions Covered||North America, Europe, APAC, Latin America, MEA|
|Historical Year||2018 to 2019 (Data from 2010 can be provided as per availability)|
|Number of Pages||228|
|Number of Tables & Figures||160|
|Customization Available||Yes, the report can be customized as per your need.|
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Type First Line Of Treatment, Second Line Of Treatment and By Application Men, Women, Children.
Some of the companies that are profiled in this report are:
Celiac Drugs Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Celiac Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Celiac Drugs Market Report:
Some other reports from this category!